IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cyclacel Pharmaceuticals Inc

Q1 2026 vs Q2 2026

Comparing institutional holders between quarters

Quarters

Q2 2026Q1 2026Q4 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
VSM Wealth Advisory, LLC
UNCHANGED
Shares1,882 from 1,882
Change0 (0%)
Value$1.6K (+$1.0K)
Filed 2026-07-23
Status
VSM Wealth Advisory, LLC
UNCHANGED1,8821,88200%$565$1.6K+$1.0K2026-07-23
Showing 1 of 1 institutions